LYZ and obesity due to melanocortin 4 receptor deficiency: Encouraged by the observed benefits of lysozyme administration in the obesity setting primarily targeting the large intestine, we next evaluated the efficacy of a short-term DSS-challenged mouse model of mild colitis.